This page is no longer current and is provided for archival and research purposes.
Ontario at the Redefining Early Stage Investments Conference (RESI)
September 21 - 23, 2022
With our unique and collaborative innovation ecosystem, Ontario is where companies come to grow and prosper. The same innovative spirit that led to the discovery of insulin in Ontario one hundred years ago has led to game-changing technologies such as 3D bioprinters and techniques to boost stem cell renewal. Come to Ontario, your destination for life sciences.
Meet Ontario’s Delegates at RESI 2022
Ontario is bringing ten companies as a part our delegation to this year’s event. Learn more about our companies, listed below.
Participants
10 in total
Able Innovations is solving the repetitive and labour-intensive task of patient transfers by developing robotic medical…
Cohesys is a Toronto-based medical device manufacturer that has developed BoneTape, a resorbable tape for bone fracture…
EmergConnect aims to change the way patients think about same-day care through a digital platform for patient self-…
Hyivy Health was created after founder Rachel Bartholomew’s recent fight with cervical cancer. She wanted to change the…
Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists…
ProteinQure has built the best computational platform for designing small exotic protein therapeutics. ProteinQure…
QuadroCore is pushing the limits within the field of Mass Spectrometer (MS) technology. The company is…
QurCan therapeutics is a biotech company developing next-generation chemo and gene therapies using its proprietary…
Quthero is an early-stage life sciences startup developing applications for its platform technology--a unique, patented…
Translucent Computing’s Emrchiver enables value-based care for better patient outcomes without vendor lock-in.…